The US Department of Health and Human Services (HHS) has withdrawn a controversial 2020 dictate that blocked the Food and Drug Administration from regulating laboratory-developed tests (LDTs), allowing the agency to impose new requirements on submissions for COVID-19 diagnostics.
The FDA’s revised policy for COVID-19 tests, issued on 15 November, says new diagnostics should get an OK from the agency in the form of a cleared emergency use...